BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3046856)

  • 1. Insulin levels after injection by jet stream and disposable syringe.
    Lucas A; Ribas L; Salinas I; Audí L; Sanmartí A; Foz M
    Diabetes Care; 1988 Mar; 11(3):298-9. PubMed ID: 3046856
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes: a practical guide to insulin injections.
    Burden M
    Nurs Stand; 1994 Apr 13-19; 8(29):25-9. PubMed ID: 8198996
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of insulin levels after injection by jet stream and disposable insulin syringe.
    Malone JI; Lowitt S; Grove NP; Shah SC
    Diabetes Care; 1986; 9(6):637-40. PubMed ID: 3542456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devices for insulin administration.
    Hill J
    Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Diabetes Association Resource Guide 2003. Insulin delivery.
    Diabetes Forecast; 2003 Jan; 56(1):59-61, 63-6, 68-71, 74-6. PubMed ID: 14765409
    [No Abstract]   [Full Text] [Related]  

  • 6. Reevaluation of single-use insulin syringes.
    McCarthy JA; Sink PF; Covarrubias BM
    Diabetes Care; 1988; 11(10):817-8. PubMed ID: 3073071
    [No Abstract]   [Full Text] [Related]  

  • 7. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 8. [The absorption of short-acting insulin administered subcutaneously in diabetic patients].
    Nakamura T; Sekino K; Kasai F; Ishii F; Kudoo M; Imamura K; Kikuchi N; Takebe K
    Probl Endokrinol (Mosk); 1993; 39(2):14-6. PubMed ID: 8016042
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new long-acting insulin analog. "Fewer hypoglycemias observed"].
    Gallwitz B
    MMW Fortschr Med; 2004 Jan; 146(3-4):47. PubMed ID: 15035450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma levels of glucose and free insulin in diabetics after insulin administration using a traditional syringe and a jet injector].
    Coscelli C; Palmari V; Saccardi F; Formica F
    Minerva Endocrinol; 1984; 9(2):309-12. PubMed ID: 6390143
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin therapy with pens and pumps].
    Schwedes U
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle injection in patients with insulin-dependent diabetes mellitus.
    Pehling GB; Gerich JE
    Mayo Clin Proc; 1984 Nov; 59(11):751-4. PubMed ID: 6387316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reuse of disposable syringe-needle sets in the diabetic patient--fact or fiction?
    Fawbush MW
    Fla Nurse; 1984 Oct; 32(10):15. PubMed ID: 6391966
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
    Hollander PA; Krasner A; Klioze S; Schwartz P; Duggan W
    Diabetes Care; 2007 Oct; 30(10):2508-10. PubMed ID: 17536080
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatrics, Pens, and Pumps.
    Hieronymus L; Hepner A; Cherolis J
    Diabetes Self Manag; 2015; 32(2):20-3. PubMed ID: 26665831
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation of the SoloSTAR insulin pen.
    Schwartz S; Vlajnic A
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus.
    Schipper C; Musholt P; Niemeyer M; Qvist M; Löffler A; Forst T; Pfützner A
    Curr Med Res Opin; 2012 Aug; 28(8):1297-303. PubMed ID: 22746353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple use of disposable syringe units by insulin-dependent diabetics.
    Turner JG; Lancaster J
    Diabetes Educ; 1984; 10(3):38-41. PubMed ID: 6386404
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.